chr3:179218304:A>G Detail (hg38) (PIK3CA)

Information

Genome

Assembly Position
hg19 chr3:178,936,092-178,936,092 View the variant detail on this assembly version.
hg38 chr3:179,218,304-179,218,304

HGVS

Type Transcript Protein
RefSeq NM_006218.3:c.1634A>G NP_006209.2:p.Glu545Gly
Ensemble ENST00000263967.4:c.1634A>G ENST00000263967.4:p.Glu545Gly
ENST00000643187.1:c.1634A>G ENST00000643187.1:p.Glu545Gly
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

ClinVar

Clinical Significance Pathogenic
Review star
Show details
Links
Type Database ID Link
Gene MIM 171834 OMIM
HGNC 8975 HGNC
Ensembl ENSG00000121879 Ensembl
NCBI NCBI
Gene Cards Gene Cards
OncoKB OncoKB
Type Database ID Link
Variant TogoVar
COSMIC COSM764 COSMIC
MONDO
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
Clinical significance Last evaluated Review status Condition Origin Links
Pathogenic 2007-08-14 no assertion criteria provided Carcinoma of colon somatic Detail
Pathogenic 2007-08-14 no assertion criteria provided epidermal nevus somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided lung adenocarcinoma somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided gallbladder carcinoma somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Neoplasm of brain somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Carcinoma of esophagus somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Nasopharyngeal neoplasm somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Papillary renal cell carcinoma type 1 somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided hepatocellular carcinoma somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Squamous cell carcinoma of the head and neck somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided gastric adenocarcinoma somatic Detail
Pathogenic 2016-05-31 no assertion criteria provided Breast neoplasm somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Squamous cell lung carcinoma somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided glioblastoma somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided uterine carcinosarcoma somatic Detail
Likely pathogenic 2015-07-14 no assertion criteria provided melanoma somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided pancreatic adenocarcinoma somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Papillary renal cell carcinoma, sporadic somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided prostate adenocarcinoma somatic Detail
Pathogenic 2016-05-31 no assertion criteria provided Neoplasm of the large intestine somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Malignant melanoma of skin somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Malignant neoplasm of body of uterus somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Small cell lung carcinoma somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided ovarian serous cystadenocarcinoma somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Neoplasm of uterine cervix somatic Detail
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
melanoma Vemurafenib D Predictive Supports Resistance Somatic 2 24265155 Detail
DisGeNET
Score Disease name Description Source Pubmed Links
0.129 ovarian neoplasm NA CLINVAR Detail
0.240 Cowden syndrome 5 NA CLINVAR Detail
0.377 liver carcinoma NA CLINVAR Detail
0.241 NEVUS, EPIDERMAL (disorder) NA CLINVAR Detail
0.131 colon carcinoma NA CLINVAR Detail
Annotation

Annotations

DescrptionSourceLinks
An in vitro study of M229 (a human melanoma cell line) endogenously expressing wildtype PIK3CA and B... CIViC Evidence Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Carcinoma of colon ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Epidermal nevus ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Lung adenocarcinoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Gallbladder carcinoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Neoplasm of brain ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Transitional cell carcinoma of the bladder ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Carcinoma of esophagus ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Nasopharyngeal neoplasm ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Papillary renal cell carcinoma type 1 ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Hepatocellular carcinoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Squamous cell carcinoma of the head and neck ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Gastric adenocarcinoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Breast neoplasm ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Squamous cell lung carcinoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Brainstem glioma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Glioblastoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Uterine carcinosarcoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Melanoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Pancreatic adenocarcinoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Papillary renal cell carcinoma, sporadic ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Prostate adenocarcinoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Neoplasm of the large intestine ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Malignant melanoma of skin ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Malignant neoplasm of body of uterus ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Small cell lung carcinoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Ovarian serous cystadenocarcinoma ClinVar Detail
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Neoplasm of uterine cervix ClinVar Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
dbSNP
rs121913274 dbSNP
Genome
hg38
Position
chr3:179,218,304-179,218,304
Variant Type
snv
Reference Allele
A
Alternative Allele
G
Variant (CIViC) (CIViC Variant)
E545G
Transcript 1 (CIViC Variant)
ENST00000263967.3
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/883
Genome browser